Search Within

Taha Merghoub

  1. "Biostatistics Service"
Formats
  1. Journal Article (25)
  2. Meeting Abstract (16)
Groups
  1. Biostatistics Service (41)
  2. Department of Medicine (41)
  3. Epidemiology and Biostatistics (41)
  4. Melanoma and Immunotherapeutics Service (41)
  5. Solid Tumor Oncology Division (41)
  6. GSK Faculty (33)

More Groups

People
  1. Jedd Wolchok (27)
  2. Katherine Panageas (18)
  3. Sadna Budhu (12)
  4. Cailian Liu (10)
  5. Matthew Hellmann (9)
  6. Billel Gasmi (8)

More People

Years
  1. 2023 (2)
  2. 2022 (6)
  3. 2021 (4)
  4. 2020 (7)
  5. 2019 (5)
  6. 2018 (8)

More Years

Publications
  1. Journal of Clinical Oncology (9)
  2. Journal for ImmunoTherapy of Cancer (5)
  3. Cancer Cell (3)
  4. Blood (2)
  5. Cancer Research (2)
  6. Clinical Cancer Research (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (10)
  2. American Association for Cancer Research (6)
  3. Biomed Central Ltd (5)
  4. Cell Press (4)
  5. Nature Publishing Group (3)
  6. American Association for the Advancement of Science (2)

More Publishers

Results (41)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular determinants of response to anti-programmed cell death (PD)-1 and anti-programmed death-ligand 1 (PD-L1) blockade in patients with non-small-cell lung cancer profiled with targeted next-generation sequencing
    Journal Article

    Rizvi, H.; Sanchez-Vega, F.; La, K.; Chatila, W.; Jonsson, P.; Halpenny, D.; Plodkowski, A.; Long, N.; Sauter, J. L.; Rekhtman, N.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Robust antitumor responses result from local chemotherapy and CTLA-4 blockade
    Journal Article

    Ariyan, C. E.; Brady, M. S.; Siegelbaum, R. H.; Hu, J.; Bello, D. M.; Rand, J.; Fisher, C.; Lefkowitz, R. A.; Panageas, K. S.; Pulitzer, M.; more...
    Cancer Immunology Research (2018)

    Fulltext@MSK | Save
  • PTEN loss-of-function alterations are associated with intrinsic resistance to BRAF inhibitors in metastatic melanoma
    Journal Article

    Catalanotti, F.; Cheng, D. T.; Shoushtari, A. N.; Johnson, D. B.; Panageas, K. S.; Momtaz, P.; Higham, C.; Won, H. H.; Harding, J. J.; Merghoub, T.; more...
    JCO Precision Oncology (2017)

    Fulltext@MSK | Save
  • Identification of unique neoantigen qualities in long-term pancreatic cancer survivors
    Meeting Abstract

    Balachandran, V.; Luksza, M.; Zhao, J. N.; Makarov, V.; Moral, J. A.; Remark, R.; Herbst, B.; Askan, G.; Bhanot, U.; Senbabaoglu, Y.; more...
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutation
    Journal Article

    Momtaz, P.; Harding, J. J.; Ariyan, C.; Coit, D. G.; Merghoub, T.; Gasmi, B.; You, D.; Viale, A.; Panageas, K. S.; Samoila, A.; more...
    Oncotarget (2017)

    Fulltext@MSK | Save
  • Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
    Journal Article

    Balachandran, V. P.; Luksza, M.; Zhao, J. N.; Makarov, V.; Moral, J. A.; Remark, R.; Herbst, B.; Askan, G.; Bhanot, U.; Senbabaoglu, Y.; more...
    Nature (2017)

    Fulltext@MSK | Save
  • Blockade of surface-bound TGF-ß on regulatory T cells abrogates suppression of effector T cell function in the tumor microenvironment
    Journal Article

    Budhu, S.; Schaer, D. A.; Li, Y.; Toledo-Crow, R.; Panageas, K.; Yang, X.; Zhong, H.; Houghton, A. N.; Silverstein, S. C.; Merghoub, T.; more...
    Science Signaling (2017)

    Fulltext@MSK | Save
  • Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer
    Journal Article

    Osorio, J. C.; Ni, A.; Chaft, J. E.; Pollina, R.; Kasler, M. K.; Stephens, D.; Rodriguez, C.; Cambridge, L.; Rizvi, H.; Wolchok, J. D.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • A retrospective evaluation of vemurafenib as treatment for BRAF-mutant melanoma brain metastases
    Journal Article

    Harding, J. J.; Catalanotti, F.; Munhoz, R. R.; Cheng, D. T.; Yaqubie, A.; Kelly, N.; McDermott, G. C.; Kersellius, R.; Merghoub, T.; Lacouture, M. E.; more...
    The Oncologist (2015)

    Fulltext@MSK | Save
  • Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs
    Journal Article

    Nakahara, T.; Uchi, H.; Lesokhin, A. M.; Avogadri, F.; Rizzuto, G. A.; Hirschhorn-Cymerman, D.; Panageas, K. S.; Merghoub, T.; Wolchok, J. D.; Houghton, A. N.
    Blood (2010)

    Fulltext@MSK | Save